Medical Marijuana, Inc. Subsidiary Kannaway® Announces Exclusive Red-Carpet Event in Denver, CO

by adminTorusBrand | Mar 16, 2017 | Kannaway, Press Releases

SAN DIEGO, March 16, 2017 — Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary, Kannaway LLC the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products is holding an exclusive Red-Carpet Event in Denver, CO., this...

RSHO-X™ at Center of New Epilepsy Study Revealing Significant Reduction of Seizures

by adminTorusBrand | Mar 14, 2017 | Company News, HempMeds Mexico, Scientific Research

[vc_row][vc_column][vc_column_text]The following information is presented for educational purposes only. Medical Marijuana Inc. provides this information to provide an understanding of the potential applications of cannabidiol. Links to third party websites do not...

Study Results: Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Announces Release of Study using its Real Scientific Hemp Oil-X™ to Treat Epileptic Children

by adminTorusBrand | Mar 14, 2017 | HempMeds Mexico, Press Releases, Scientific Research

The following information is presented for educational purposes only. Medical Marijuana Inc. provides this information to provide an understanding of the potential applications of cannabidiol. Links to third party websites do not constitute an endorsement of these...

Dope Magazine Features Medical Marijuana, Inc. Subsidiary HempMeds® Mexico In Historic ‘Look At America’s Reverse-Cannabis Pipeline’

by adminTorusBrand | Mar 8, 2017 | HempMeds Mexico, Press Releases, Scientific Research

Article Also Details Company’s Pioneering Role in Latin America’s Burgeoning Cannabis Market SAN DIEGO, March 8, 2017 — Medical Marijuana, Inc. (OTC:MJNA) announced today that its subsidiary HempMeds® Mexico, the first company to receive government...

AXIM® Biotechnologies Starts Phase II Clinical Trial for IBS Treatment

by adminTorusBrand | Mar 7, 2017 | Axim Biotechnologies, Canchew, Company News

[vc_row][vc_column][vc_column_text]Medical Marijuana, Inc. investment company AXIM® Biotechnologies has announced it has completed enrollment of the required 40 patients for its Phase II clinical trial for CanChew Plus® CBD gum for the treatment of irritable bowel...